Godavari Drugs Limited (BOM:530317)

Market Cap	913.83M +26.3%
Revenue (ttm)	1.07B -6.6%
Net Income	40.89M -6.6%
EPS	5.36 -7.9%
Shares Out	7.53M
PE Ratio	22.64
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,033
Open	128.00
Previous Close	125.40
Day's Range	121.00 - 128.00
52-Week Range	69.70 - 135.25
Beta	0.35
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 13, 2026

About Godavari Drugs

Godavari Drugs Limited manufactures and sells active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. The company offers APIs, including ciprofloxacin HCl, ciprofloxacin lactate, ciprofloxacin betaine, mefenamic acid, enrofloxacin, and elthambutoal HCI; and intermediaries, such as A D lactone for spironolactone and 6 mercaptopurine for azathioprine. It also provides loan licenses and contract manufacturing services for APIs and drug intermediates. The company serves the life science industry. Godavari Drugs L...

• Industry: Pharmaceutical Preparations
• Founded: 1987
• Employees: 106
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 530317

Financial Performance

In fiscal year 2026, Godavari Drugs's revenue was 1.07 billion, a decrease of -6.57% compared to the previous year's 1.14 billion. Earnings were 40.89 million, a decrease of -6.64%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jul 8, 2026

Data Sources Report a data error